South Africa: New Vaccine Trial Shows Promise Against 'Severe' Covid-19

[Daily Maverick] 'Brilliant news,' says J&J principal investigator of the South African arm Professor Glenda Gray who herself enrolled in another vaccine trial. But vaccine efficacy of the single-shot J&J jab is lower in the variant now dominant in South Africa than in global trial results